|
A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction
J Am Coll Cardiol. 2005 Ene; 45(1):25-9.
Marin F, Gonzalez-Conejero R, Lee KW, Corral J, Roldan V, Lopez F, Sogorb F, Caturla J, Lip GY, Vicente V |
|
Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction
Thromb Haemost. 2005 Ene; 93(1):35-9.
Steppich B, Mattisek C, Sobczyk D, Kastrati A, Schomig A, Ott I |
|
A new global assay of coagulation and fibrinolysis
Thromb Res. 2005 Ene; 116(4):345-56. Epub 2005 Ene 20
Goldenberg NA, Hathaway WE, Jacobson L, Manco-Johnson MJ |
|
Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant?
Am J Cardiovasc Drugs. 2005 Ene; 5(4):211-23.
Fogari R, Zoppi A |
|
FXIII polymorphisms, fibrin clot structure and thrombotic risk
Biophys Chem. 2004 Dic; 112(2-3):223-8.
Kobbervig C, Williams E |
|
Factor VLeiden inhibits fibrinolysis in vivo
Circulation. 2004 Dic; 110(23):3594-8. Epub 2004 Nov 29
Parker AC, Mundada LV, Schmaier AH, Fay WP |
|
Thrombin activatable fibrinolysis inhibitor and its fibrinolytic effect in normal pregnancy
Thromb Haemost. 2004 Nov; 92(5):1025-31.
Mousa HA, Downey C, Alfirevic Z, Toh CH |
|
A central role for plasminogen in the inflammatory response to biomaterials
J Thromb Haemost. 2004 Oct; 2(10):1798-805.
Busuttil SJ, Ploplis VA, Castellino FJ, Tang L, Eaton JW, Plow EF |
|
Admission Fibrinolytic Profile Is Associated With Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Tissue Plasminogen Activator.
Stroke. 2004 Sep; 35(9):2123-7. Epub 2004 Jul 8
Ribo M, Montaner J, Molina CA, Arenillas JF, Santamarina E, Quintana M, Alvarez-Sabin |
|
Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia
J Thromb Haemost. 2004 Ago; 2(8):1341-50.
Tallman MS, Lefebvre P, Baine RM, Shoji M, Cohen I, Green D, Kwaan HC, Paietta E, Rickles FR |
|
Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population
Am J Hematol. 2004 Ago; 76(4):348-52.
Santamaria A, Borrell M, Oliver A, Ortin R, Forner R, Coll I, Mateo J, Souto JC, Fontcuberta J |
|
Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level.
Haematologica. 2004 Jul; 89(7):880-1.
Santamaria A, Martinez-Rubio A, Borrell M, Mateo J, Ortin R, Fontcuberta J. |
|
Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
Stroke. 2004 Jul; 35(7):1671-6. Epub 2004 May 27
Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Davalos A. |
|
Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels
Thromb Haemost. 2004 Jul; 92(1):54-60.
Gori AM, Marcucci R, Fatini C, Gensini F, Sticchi E, Sodi A, Cappelli S, Menchini U, Gensini GF, Abbate R, Prisco D |
|
Clopidogrel does not induce fibrinolysis in healthy subjects
In Press, Corrected Proof. 2004 Jun; Available online 2004 Jun 7
Taha H. Taher, Linda Stang, Philip A. Gordon and Paul W. Armstrong |
|
Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
Stroke. 2004 Jun; 35(6):1490-7. Epub 2004 Abr 22
Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, Lewis S, Lindley R, Neilson A, Wardlaw J. |
|
Structure of uPAR, plasminogen, and sugar-binding sites of the 300 kDa mannose 6-phosphate receptor.
EMBO J.. 2004 May; 23(10):2019-28. Epub 2004 Abr 15
Olson LJ, Yammani RD, DahmsNM, Kim JJ |
|
Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism.
Blood. 2004 May; 103(10):3773-6. Epub 2004 Ene 22
Eichinger S, Schonauer V, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Schneider B, Quehenberger P, Kyrle PA |
|
A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion
Blood. 2004 May; 103(10):3783-8. Epub 2004 Ene 29
Lee KN, Jackson KW, Christiansen VJ, Chung KH, McKee PA |
|
Nicked beta2-glycoprotein I: A marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis.
Blood. 2004 May; 103(10):3766-72. Epub 2004 Ene 15
Yasuda S, Atsumi T, Ieko M, Matsuura E, Kobayashi K, Inagaki J, Kato H, Tanaka H, Yamakado M, Akino M, Saitou H, Amasaki Y, Jodo S, Amengual O, Koike T. |
